Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Advocating for Patients With Chronic Lymphocytic Leukemia

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

While attending the American Society of Hematology (ASH) Annual Meeting held in New Orleans, LA, in December 2022, CLL Society Executive Vice President Dr. Brian Koffman was interviewed by CGTLive, a healthcare provider geared outlet that reports on cell, gene, regenerative, and engineered medicines. During the interview, Dr. Koffman shared his journey with CLL and the origins of the organization, CLL Society. Dr. Koffman also spoke about where he feels cell and gene therapy, like CAR-T therapy, is going for treating chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL / SLL).

You can read the full article from CGTLive here: Advocating for Patients With Chronic Lymphocytic Leukemia.